UNSPSC 85811304: Introduction of liquid brachytherapy radioisotope into pericardial cavity, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of liquid brachytherapy radioisotope into pericardial cavity, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0Y704

UNSPSC 85811304 Introduction of liquid brachytherapy radioisotope into pericardial cavity, via natural or artificial opening is a Commodity code that does not align with the state and local procurement activity captured in the recent opportunities dataset. The code nominally describes an invasive oncology procedure—intrapericardial brachytherapy delivery—but none of the state and local opportunities posted under this code reflect procurement of that service or related clinical capability. Instead, the recent solicitations tagged to this code span telehealth urgent care (Inland Empire Health Plan, California), general medical services (DeKalb County, Georgia), senior-focused care coordination (Nevada Health Authority PACE program), and rural healthcare facilitation (Nevada RVAN vendor), none of which involve radiation therapy, brachytherapy, or pericardial intervention. The code shows little relevant recent activity and appears to reflect a data-coding mismatch between the nominal commodity description and the work actually being bought under it by state and local governments.

The recent opportunities under this code originate from health systems and state health authorities in California, Georgia, and Nevada, along with scattered municipal and county health procurements across the country. Issuing bodies include regional health plans, state Medicaid agencies, county public health systems, and city and county government employee health programs. Activity clusters around telehealth service delivery, managed-care operations, occupational health screenings, crisis stabilization, and behavioral health integration—service areas far removed from interventional oncology. No opportunities in the dataset reference brachytherapy, radioisotope therapy, cardiology procedures, or cancer treatment delivery. Geographic spread encompasses California, Georgia, Nevada, Colorado, Kansas, Texas, Florida, New York, and other states, but with no concentration in any particular region and no visible pattern suggesting demand for the pericardial brachytherapy procedure the code nominally describes. Business development professionals evaluating this code should treat it as inactive for its stated scope and verify the actual commodity procurement need directly with issuing agencies rather than relying on the code classification.